Intrathecal Pumps Market sustained growth by key vendors Codman & Shurtleff, Medtronic plc, Arrow International, Medallion Therapeutics, Flowonix

Intrathecal pump device is expected to evolve with several companies working on new technologies that would improve the functioning of programmable pump, internal mechanism, and safety. In 2014, Food and Drug Administration (FDA) approved the ‘Prometra’ intrathecal pump launched by Flowonix Medical Inc. ‘Prometra’ have various features, such as accurate drug delivery system, dual-gated valve drug distribution, and improved device durability. The other area of interest in the intrathecal space is the development of new drugs that could be delivered to treat specific alignments. For instance, FDA approved number of medications, such as Ziconotide (2004), Spinraza (2016), and probuphine (2016), which have been proven to be safe for intrathecal administration.

Get PDF Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/935

Some of the key players in intrathecal pumps market are Codman & Shurtleff, Medtronic plc, Arrow International, Medallion Therapeutics, Flowonix, and Tricumed GmbH.

Major changes in the pump therapy for chronic diseases are likely to be observed during the forecast period 2017-2025. Intrathecal pumps are widely used to relive chronic pain in cancer. According to a survey conducted by the International Agency for Research on Cancer (IARC) in 2012, new cases of cancer were estimated to be 14.1 million and mortality rate was approximately 8.2 million. According to a survey conducted by the World Health Organization (WHO) and International Pain Community in 2011, the prevalence of chronic pain in cancer was evaluated around 25% for newly identified patients and greater than 75% for patients with progressive disease. The demand for advanced intrathecal pumps will extensively upsurge in future with increasing cases of chronic illnesses.

Drugs used in intrathecal drug delivery pumps consist mainly of opioids, adrenergic agonists, N-methyl-D-aspartate receptor agonists, local anesthetics, and other agents. As most of the drugs delivered through intrathecal pumps are analgesics, pain management accounts for the largest share in the global intrathecal pumps market followed by spasticity management.

Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/935

Global Intrathecal Pumps Market Taxonomy

On the basis of medication type, the Intrathecal pumps market is segmented into:

Baclofen
Hydromorphone
Morphine
Clonidine
Midazolam
Bupivacaine
Others
On the basis of application, the global Intrathecal pumps market is segmented into:

Pain Management
Spasticity Management (Continuous muscle contraction)

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.